Something to note: oral treatment & if successful:
https://www.google.com.au/amp/s/www.nytimes.com/2021/10/17/health/covid-treatment-access-molnupiravir.amp.html
3% vaccination rate across Africa, quoted in this article. That’s appalling. Oral treatments for COVID-19 should know no boundaries. They don’t need cold-chain nor expense or expertise to hospitals administering IV expensive MABS. Other Drug companies (ie Merck) will allow out-licensing with cheaper cost to Govts/patients for oral antivirals +/- WHO support.
https://www.reuters.com/business/healthcare-pharmaceuticals/aurobindo-pharma-stop-molnupiravir-trial-moderate-covid-19-patients-2021-10-08/
Interesting article above on Molnupiravir trials in India.
GLTAH
- Forums
- ASX - By Stock
- DXB Chart
Something to note: oral treatment & if...
-
- There are more pages in this discussion • 741 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DXB (ASX) to my watchlist
(20min delay)
|
|||||
Last
34.0¢ |
Change
-0.005(1.45%) |
Mkt cap ! $186.8M |
Open | High | Low | Value | Volume |
34.5¢ | 35.5¢ | 33.5¢ | $1.194M | 3.480M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 181739 | 34.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
34.5¢ | 395705 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 181739 | 0.340 |
10 | 143721 | 0.335 |
10 | 334459 | 0.330 |
7 | 335827 | 0.325 |
9 | 286118 | 0.320 |
Price($) | Vol. | No. |
---|---|---|
0.345 | 395705 | 4 |
0.350 | 665467 | 5 |
0.355 | 55783 | 3 |
0.360 | 346019 | 7 |
0.365 | 258910 | 4 |
Last trade - 16.10pm 22/05/2024 (20 minute delay) ? |
|
|||||
Last
34.0¢ |
  |
Change
-0.005 ( 1.45 %) |
|||
Open | High | Low | Volume | ||
35.0¢ | 35.5¢ | 33.5¢ | 1411237 | ||
Last updated 15.59pm 22/05/2024 ? |
Featured News
DXB (ASX) Chart |
The Watchlist
RDN
RAIDEN RESOURCES LIMITED
Dusko Ljubojevic, MD
Dusko Ljubojevic
MD
SPONSORED BY The Market Online